TRIB — Trinity Biotech Share News
0.000.00%
Last trade - 00:00- $5.11m
- $137.96m
- $43.79m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Ireland's Trinity Biotech Q1 revenue rises on HIV test sales
Brief: Trinity Biotech - Enters ATM Offering Agreement With Lucid Capital Markets For ADS Sale - SEC Filing
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla
Trinity Biotech rises as prostate cancer test shows strong accuracy
Brief: Trinity Biotech Announces Collaboration With University At Buffalo To Commercialize Novel Biomarkers For Sjögren’S Syndrome
Brief: Trinity Biotech Secures $25 Million Financing Commitment
Brief: Trinity Biotech Secures Regulatory Approval For Commencement Of Upstream Manufacturing Activities Of Uni-Gold™ HIV Rapid Test
Brief: Trinity Biotech Announces Agreements To Strengthen Capital Structure And Support Growth Initiatives
Brief: Trinity Biotech Awarded A Major Order For 9 Million Trinscreen HIV Tests
Receives Who Approval For Uni-Gold Hiv Test
Welcomes Primary Lender Perceptive Advisors' Debt-To-Equity Conversion Proposal
Trinity Biotech soars on glucose monitoring sensor trial data